Article
Accessing anti-HIV activity through the attenuation of USP18 activity: novel insights from…
medRxiv · 2024 · Sigauke, L. T.; Bvunzawabaya, J.; Le Bury, G.; Dziwornu, G. A.; Boliar, S.; Gludish, D. W.; Russell, D. G.; Govender, K.; Mugumbate, G.; Chigorimbo-Murefu, N.
Key facts
| Title | Accessing anti-HIV activity through the attenuation of USP18 activity: novel insights from molecular dynamic simulations, free-energy profiling, and multi-cellular inhibition assays |
|---|---|
| First author | Sigauke, L. T.; Bvunzawabaya, J.; Le Bury, G.; Dziwornu, G. A.; Boliar, S.; Gludish, D. W.; Russell, D. G.; Govender, K.; Mugumbate, G.; Chigorimbo-Murefu, N. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.06.23.600290 |
| Devices mentioned | K103302 |
| Product codes mentioned | KIT, NDS, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1